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Objective: Spontaneous isolated dissection of the superior mesenteric artery (SIDSMA) is extremely rare. Various
treatment options are currently available, including conservative management, anticoagulation, endovascular stenting,
and surgical repair. Herein, we present our experience in the treatment of symptomatic SIDSMA.
Methods: A retrospective study was conducted on 14 consecutive patients with symptomatic SIDSMA between January
2000 and January 2010. All patients had acute onset abdominal pain. The decision to intervene was based on patient
symptoms and signs, as well as the morphologic characteristics of superior mesenteric artery (SMA) dissection on
computed tomography (CT) angiography. Endovascular stenting (ES) was indicated in patients with severe compression
of the true lumen or dissecting aneurysm likely to rupture. Self-expandable stents were placed via a right common femoral
approach. None of the patients underwent anticoagulation, and patients who underwent ES were maintained on
antiplatelet therapy for 3 months postoperatively.
Results: The median age of the study subjects was 59 years (range, 50-75 years). The median follow-up time was 27.5
months (range, 2-64 months). Treatment included conservative management without the use of anticoagulation in seven
patients, ES in six, and necrotic bowel resection in one. Four patients with severe compression of the true lumen or large
dissecting aneurysm underwent ES as a primary treatment. ES was additionally performed in two patients in whom initial
conservative treatment failed (increasing dissecting aneurysm at 7-day follow-up CT scan in one and a reappearance of
abdominal pain after resuming diet in the other). The median fasting time was significantly shorter in patients with
primary ES (2.5 days) than in those managed conservatively (8.0 days). No complications associated with the SIDSMA
or ES were developed. The patency of stents was demonstrated on follow-up CT scans up to 60 months (range, 1-60
months).
Conclusions: Conservative management without anticoagulation can be applied successfully to the patients with symp-
tomatic SIDSMA. Primary endovascular stenting is indicated if patients have suspected bowel ischemia, compression of
the true lumen of the SMA >80%, or SMA aneurysm of >2.0 cm in diameter on initial CT scan. Endovascular stenting
can also be provided to the patients in whom initial conservative treatment failed, as a rescue therapy. (J Vasc Surg 2011;
54:461-6.)
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aSpontaneous isolated dissection of superior mesenteric
artery (SIDSMA) is a clinically rare disease; less than 150
cases without associated aortic dissection have been re-
ported in the literature.1-23 With technical advances in
multidetector computed tomography (CT), improved CT
resolution and the increasing popularity of CT for investi-
gating abdominal pain, however, SIDSMA has been re-
ported more frequently in recent years.11 SIDSMA is asso-
ciated with a broad spectrum of clinical pictures, from
asymptomatic incidental findings to acute catastrophic
bowel ischemia/infarction or aneurismal superior mesen-
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doi:10.1016/j.jvs.2011.03.001eric artery (SMA) rupture. A variety of treatment options
ave also been described for SIDSMA, including conserva-
ive management, anticoagulation, endovascular stenting
ES), and open surgical repair. Although some patients
ith no or mild symptoms can be successfully managed
ith conservative management regimens,19 whether or not
nticoagulation should be used in cases of asymptomatic
IDSMA remains a matter of some controversy. In cases of
ymptomatic SIDSMA, moreover, there is currently no
onsensus as to an appropriate treatment protocol.
Herein, we report a contemporary series of 14 cases
resenting with acute abdominal pain and describe the
anagement strategy we adopted in cases of symptomatic
IDSMA, based on our experience and the current litera-
ure.
ETHODS
A retrospective study was performed on 14 consecutive
atients (12 male, 2 female) with symptomatic SIDSMA
etween January 2000 and January 2010 after obtaining
pproval from the Institutional Review Board. All patients
resented with acute-onset abdominal pain. The diagnosis
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August 2011462 Min et alof SIDSMA was made by the characteristic CT findings24
including thrombosis of the false lumen, intramural hema-
toma, and/or intimal flap (Fig 1).
Conservative management for a patient with symptom-
atic SIDSMA consisted of strict blood pressure control,
bowel rest, and close observation, without the use of anti-
coagulation or antiplatelet agents. Endovascular manage-
ment included self-expandable stent placement via a right
common femoral artery approach and antiplatelet therapy
for 3 months postoperatively. Self-expandable stents were
sized to the diameter of the normal proximal SMA and
stents 10% greater in diameter were chosen. The SMA was
selectively catheterized with a 6 Fr renal double curve
(RDC) catheter (Cordis Corporation, Bridgewater, NJ).
Because the SMA dissection usually begins 1.0 to 3.0 cm
from the orifice of the SMA, a self-expandable stent was
placed in the true lumen over the SV5 guidewire (Cordis
Endovascular, Bridgewater, NJ) so that the proximal end of
the stent was at the orifice of the SMA. SIDSMA compli-
cated with bowel infarction or arterial rupture was surgi-
cally treated.
The decision to manage conservatively, to place a stent,
or to undergo surgery was based on patient symptoms and
signs, as well as the morphologic characteristics of SMA
dissection on CT angiography. The factors indicating ES
included severe compression of the true lumen (more than
80% compared with adjacent normal SMA diameter), and
aneurysmal dilation of the SMA likely to rupture on initial
CT, which was larger than 2 cm in diameter25,26 (Fig 2).
Aggravation of pain or increasing size of aneurysmal dila-
tion of the SMA at follow-up CT were also considered
indicative of ES in patients undergoing conservative man-
Fig 1. Repeated computed tomography (CT) scans in long-term
follow-up patients. A, Conservative management without antico-
agulation resulted in successful thrombosis and obliteration of the
false lumen. B, Endovascular stenting resulted in complete oblit-
eration of the false lumen. Patency of the superior mesenteric
artery (SMA) stent is demonstrated up to 60 months postopera-
tively without in-stent restenosis. m, Month.agement. SAneurysmal dilatation of SMA was defined as an in-
rease in diameter of more than 50% relative to the normal
aliber of the SMA for each patient, as measured by a CT
can. The percentage of true lumen compression by the
alse lumen was also calculated from the CT scan. The
ollow-up consisted of a physical examination and adjunc-
ive CT at 1 month, 6 months, and yearly thereafter. In
atients with conservative management, CT was addition-
lly checked at any time with aggravation of symptoms
uring the early period of the hospital course or 7 days after
he initial diagnosis. Diet was resumed after complete res-
lution of abdominal pain and confirmation of normal
hysical examination and laboratory data for more than 2
onsecutive days in patients with conservative treatment.
T findings at the 7-day follow-up CT scans are also a
seful indicator for resumption of diet.
Statistical analysis was conducted via Fisher’s exact test
nd 2 test using SPSS software (version 15.0; SPSS Inc,
hicago, Ill). P values of.05 were considered statistically
ignificant.
ESULTS
The median age of the patients was 59 years (range,
0-74 years), and the median follow-up time was 27.5
onths (range, 2-64 months). Relevant comorbidities in-
luded hypertension (21.4%), diabetes mellitus (7.1%),
trial fibrillation (7.1%), and dilated cardiomyopathy
7.1%). No patients had identifiable risk factors such as
hler’s syndrome, Marfan’s syndrome, segmental arterial
ediolysis, trauma, fibromuscular dysplasia, or vasculitis.
ll patients had acute onset abdominal pain at presentation.
ig 2. Reconstructed computed tomography (CT) angiography
ndings indicated for primary endovascular stenting. A, Severe
ompression of the true lumen and (B) a patent superiormesenteric
rtery stent and complete obliteration of the false lumen at 60-month
ollow-up CT in patient no. 12. C, Large dissecting aneurysm (20.0
m in diameter) and (D) near complete disappearance of the aneu-
ysm at 36-month follow-up CT in patient no. 13.even patients underwent conservative management with-
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Volume 54, Number 2 Min et al 463out anticoagulation. Six patients were treated by ES, as an
initial treatment in four patients and after the failure of
initial conservativemanagement in two patients. No patient
received an open repair. One patient with bowel infarction
suspected from an initial CT scan underwent emergent
surgery. ES or surgical bypass was not attempted and 200
cm of the necrotic bowel segment was resected. Only 70 cm
of terminal ileum was saved. This patient was discharged 1
month after surgery.
The median distance from the SMA ostium to the
beginning of SMA dissection is 16.4 mm (range, 9.2-29.6
mm). The median length of SMA dissection was 80.0 mm
(range, 33.0-130.0mm), and there was no difference in the
length of SMA dissection between the conservative treat-
ment and ES groups (P  .54). The median diameter of
dissected SMA was 12.5 mm (range, 9.9-20.0 mm). Eight
patients evidenced aneurysmal dilatation, which is defined
as a diameter 50% larger than that of normal SMA. A
patient with a large SMA aneurysm of 20.0 mm in diameter
(patient no. 13) underwent emergency ES, but aneurysmal
dilatation of the SMA in other patients did not affect the
decision regarding the treatment method. Patients treated
with ES evidenced significantly reduced true lumen diam-
eters relative to the patients who were conservatively man-
aged (80.3 4.4% vs 50.8 7.5%, respectively; P .014).
Themorphologic characteristics of SMA dissection for each
patient are summarized in the Table.
Conservative management was initially tried in nine
patients. No patients were treated with anticoagulation or
antiplatelet therapy. Among them, seven patients were
Table. Summary of symptomatic spontaneous isolated dis
conservative management or ES
Patient
No
Age
(years)
Distance
from
SMA Os
True lumen
compression (%)
Max
diameter
of SMA Initial treat
1 65 17.4 mm 67.9 11.9 mm Conservative
2 57 16.4 mm 60.3 12.1 mm Conservative
3 63 11.9 mm 77.3 13.0 mm Conservative
4 50 10.0 mm 27.3 11.9 mm Conservative
5 55 13.5 mm 44.6 13.8 mm Conservative
6 58 9.7 mm 24.7 14.8 mm Conservative
7 56 21.4 mm 53.5 9.9 mm Conservative
8 52 9.2 mm 81.1 13.6 mm 8  40 mm
Zilver sten
9 62 24.2 mm 77.5 12.9 mm Conservative
10 52 25.2 mm 91.9 12.2 mm 8  40 mm
Zilver sten
11 72 29.0 mm 80.2 12.5 mm 8  60 mm
Zilver sten
12 58 13.3 mm 89.7 12.4 mm Conservative
13 56 29.6 mm 61.7 20.0 mm 8  38 mm
Wallstent
ES, Endovascular stent; F/U, follow-up; O, obliterated false lumen; P, patensuccessfully treated with a median follow-up period of 15.0 ronths (range, 2-61 months), and serial CT scans demon-
trated thrombosis and obliteration of the false lumen with
ime as depicted in Fig 1, A (patient no. 5). The median
asting time was 8.0 days (range, 2-18 days), the abdominal
ain was resolved, and the patients were discharged without
ny significant complications. No complications associated
ith SMA dissection occurred during follow-up. Two pa-
ients, who were treated initially with conservative manage-
ent, underwent additional ES. Patient no. 9 evidenced an
ncreasing diameter of SMA aneurysm from 12.5 mm to
2.9 mm at the 7-day follow-up CT scan. Patient no. 12
uffered from the reappearance of abdominal pain with
esumption of diet after 7 days of conservative manage-
ent. These two patients were treated successfully with
dditional ES.
Four patients underwent primary ES. Self-expandable
tents (Wallstent; Boston Scientific Co, Natick, Mass; Zil-
er stent; Cook Medical, Bloomington, Ind) with diame-
ers of up to 10 mm and overall lengths of up to 60 mm
ere used. The median fasting time was 2.5 days (range,
-4 days), which was significantly shorter than in the con-
ervativemanagement group (P .008). Two patients who
nderwent ES after failure of conservative management
equired an additional 2 days of fasting time after ES, and
he total fasting time in these patients was longer: 11 days
nd 9 days, respectively. Stent placement resulted in com-
lete obliteration of the false lumen and the restoration of
xcellent distal blood flow, and abdominal pain was com-
letely resolved postoperatively in all patients. The median
ollow-up was 32.5 months (range, 2-64 months), and
n of the superior mesenteric artery treated with
Outcome
Fasting time
(days)
SMA at last
F/U computed
tomography
F/U
months
Pain resolution 8 O 26
Pain resolution 8 O 32
Pain resolution 18 O 2
Pain resolution 5 O 9
Pain resolution 8 O 61
Pain resolution 2 O 15
Pain resolution 4 O 14
Pain resolution 2 O, P 32
Failed
7  40 mm
Zilver stent
9  2 (After
ES)
O, P 29
Pain resolution 3 O, P 2
Pain resolution 3 O, P 51
Failed
10  20 mm
Wallstent
7  2 (After
ES)
O, P 64
Pain resolution 1 O, P 36
t; SMA, superior mesenteric artery.sectio
ment
t
t
tepeated CT scans demonstrated the patency of the SMA
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August 2011464 Min et alstents for up to 60 months without any in-stent restenosis
(Patient no. 12, Fig 1, B). No ES-related complications
were developed. The treatments and outcomes of each
patient are summarized in detail in the Table.
DISCUSSION
SIDSMA without aortic dissection is a very rare condi-
tion. The postmortem study revealed an incidence of 0.06%
in a series of 6666 autopsies.27 Recently, however,
SIDSMA has been reported more frequently.1-3,5-12,15-22
SIDSMA can be detected as an incidental finding, but may
also cause drastic complications such as bowel infarction and
severe hemorrhage. Although four approaches – conservative
management, anticoagulation, endovascular stenting, and
open surgery – have been previously reported, given the
paucity of the SMA dissections, the optimal treatment for
SIDSMA remains a matter of some controversy.
The natural course of SMA dissection would be as
follows4,9: (1) limited progression with thrombosis of the
false lumen; (2) progressive dissection to distal branches of
the SMA; (3) rupture through the adventitia; or (4) rapidly
expanding false lumen resulting in the narrowing or oblit-
eration of the true lumen. Thus, the primary objective of
treatment in SIDSMA is to limit the extension of dissec-
tion, to preserve the blood flow distally through the true
lumen, and to prevent the rupture of the SMA. It should be
emphasized that the aforementioned treatment objectives
can be achieved by the thrombosis and obliteration of the
false lumen. Some authors insist that anticoagulation ther-
apy is valid and should be a mainstay for the conservative
management of SIDSMA after the first successful treatment
with intravenous heparin (Ambo et al).14,21,23 This opinion
has been strengthened by the experience with treatment of
spontaneous dissection of the carotid artery, where antico-
agulation is effective in preventing the formation of the
thrombus.28 Considering the aforementioned treatment
objectives of the SIDSMA and the previous reports3,10 that
have described the progression of disease and aneurysmal
dilatation in some cases despite the administration of
chronic anticoagulation therapy, anticoagulation or anti-
platelet therapy could not be the optimal treatment for
SIDSMA. Additionally, Gobble et al19 recently reviewed
106 isolated dissections of the SMA and reported that 12
(30.0%) among 43 patients (excluding cases diagnosed on
autopsy) with expectant therapy failed and 8 (34.8%) out of
23 patients with anticoagulation failed. Moreover, antico-
agulation required a prolonged fasting period of up to 33
days (27.2 days on average).14 In our series, seven patients
(77.8%) with symptomatic SIDSMA were treated success-
fully by conservative management without anticoagulation,
and the median fasting time (8.0 days) was significantly
reduced.
In the modern endovascular era, the use of percutane-
ous endovascular techniques for the SMA lesion has be-
come feasible in a variety of conditions.29-31 A stent used
for SMA needs to have minimal shortening and good
flexibility, and it must not change location as a result of the
continuous movement of the mesentery.18 ES to the entry bear site of SMA dissection can cover the intimal flap and
cclude blood inflow to the false lumen. The false lumen
hen is obliterated by thrombosis. Radial force of the self-
xpandable stent can easily overcome the pressure of the
alse lumen, which is usually caused by fresh thrombus and
tent also provide sufficient diameter of the true lumen.
ome authors18 favored stent graft in the treatment of the
IDSMA. As the stent graft can cause the obliteration of
ultiple side branches of the SMA, however, it is not
sually recommended. Stent graft can be successfully used
o cover the dissecting broad-base pseudoaneurysm of the
MA of which intimal flap cannot be covered by open
tent.7
ES for the treatment of SIDSMA was initially reported
y Leung et al.16 Since that time, 16 patients with SIDSMA
ave been treated with ES.3,5-7,12,15-20,22 ES was offered as
n initial treatment for aneurysmal dilation or bowel isch-
mia in nine patients and secondary to failed conservative
reatment with or without anticoagulation in seven pa-
ients. ES provided immediate symptomatic improvement
nd prevented further progression of the SMA dissection
ith a shorter fasting time. In our series, four patients
nderwent primary ES for severe compression of the true
umen (patients no. 8, 10, and 11) or large aneurysmal
ilation (patient no. 13). Secondary ES after failed conser-
ative management was required in two patients; patient
o. 9 evidenced increasing SMA aneurysm on a short-term
ollow-up CT scan, and patient no. 12 who had a near
cclusion of the true lumen on initial CT scan suffered from
he reappearance of abdominal pain after the resumption of
iet. Patients with ES evidenced immediate pain relief and
hort fasting time. With a median follow-up of 32.5
onths, the patency of the stents was demonstrated by
epeated CT scans of up to 60 months, which was the
ongest follow-up case. Therefore, ES can be administered
s an initial treatment to patients with large aneurysmal
ilation of the SMA likely to rupture and in patients with
evere compression of true lumen resulting in bowel isch-
mia (Fig 2). ES can also be provided as a rescue therapy in
atients with failed conservative treatment. Because the
ecurrence of an aneurysm 4 months after treatment with
S was reported,18 which was treated with another stent,
atients treated with either conservative management or ES
hould be followed up regularly.
Based on our experience and the current literature, we
ropose the following algorithm for the treatment of a
ymptomatic SIDSMA (Fig 3). Patients with a symptom-
tic SIDSMA should initially undergo conservative man-
gement without anticoagulation and antiplatelet therapy if
owel perfusion is not compromised and if the SMA aneu-
ysm is not likely to rupture. ES is indicated if patients have
uspected bowel ischemia, compression of the true lumen
f the SMA80%, or SMA aneurysm2.0 cm in diameter
n initial CT scan. Emergent open repair of dissection and
hrombectomy is indicated in patients with SMA thrombo-
is and questionable bowel viability. In cases of bowel
ecrosis or severe hemorrhage, emergent surgery such as
owel resection or open repair is indicated. Patients initially
11
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Volume 54, Number 2 Min et al 465treated with conservative management should be moni-
tored closely and should undergo a follow-up CT scan at 7
days. In cases involving aggravating symptoms, no major
relief of pain within 7 days, or progression of SMA dissec-
tion on follow-up CT scan at 7 days, ES should be consid-
ered without delay. Imaging surveillance in successfully
treated patients, either by conservative treatment or ES,
should include CT scans at 1 month, 6 months, and yearly
thereafter. Open surgery is indicated in cases of failed ES.
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